Following an abbreviated submission
trospium chloride (Flotros) is accepted for use in NHS Scotland for symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder (e.g. idiopathic or neurologic detrusor overactivity).
In patients for whom an immediate-release formulation of trospium chloride is an appropriate treatment, this preparation offers an alternative to an existing preparation at a lower cost.
Download detailed advice48KB (PDF)
- Medicine name:
- trospium chloride 20 mg film-coated tablets (Flotros)
- SMC ID:
- urge incontinence and/or increased urinary frequency and urgency
- Pharmaceutical company
- Galen Ltd
- BNF chapter
- Obstetrics, gynaecology, and urinary-tract disorders
- Submission type
- Date advice published
- 08 February 2010